Andrew L. Freeman, M.D.

Locations

Bio

Dr. Freeman is an Assistant Professor in the Division of General Internal Medicine at University Hospital. He completed medical school at the University of Colorado in 2005, followed by residency training in Internal Medicine at the University of Utah and ultimately joined the faculty here in 2008 as a full time Hospitalist. His clinical focus includes caring for patients who require hospitalization on the general medical wards with a wide variety of medical conditions. He has developed an interest in the optimal treatment of patients with healthcare associated pneumonia that may be due to resistant organisms. His additional clinical interests including assisting patients and families with difficult symptom management and complex medical decision making as a consulting physician on the University Hospital Palliative Care Service. Dr. Freeman also assists with research and consultative support for patients with blood clotting disorders as part of the University of Utah Thrombosis Service.

Board Certification and Academic Information

Board Certification and Academic Information

Academic Office Locations

Academic Bio

Dr. Freeman is a Clinical Assistant Professor in the Department of Internal Medicine at University Hospital. After completing medical school at the University of Colorado Health Sciences Center and residency training at the University of Utah, he joined the Internal Medicine faculty at the University of Utah in 2008 as a full time Hospitalist. As an Internal Medicine Hospitalist his core academic interests include teaching medicine to residents and students, as well as providing care for a number of conditions commonly affecting hospitalized medical patients.

Dr. Freeman is also a member of the University of Utah Thrombosis Service. Venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis, is a common presenting or complicating diagnosis for many hospitalized medical patients. Dr. Freeman has been involved with a number of clinical trials examining the safety and efficacy of novel anticoagulants in both the treatment and prevention of VTE. In addition, he has conducted research optimizing dosing regimens of a low-molecular weight heparin, enoxaparin, for the prevention of VTE in morbidly obese medical patients.

In addition to academic responsibilities on the general medical wards, Dr. Freeman has been a member of the University Hospital Palliative Care team since 2009. He considers it a true privilege to care for and guide decision making in patients with terminal or chronically debilitating conditions and is enthusiastic about teaching about this important specialty.

Education History

Selected Provider Publications